OncoSec Medical Receives Phase I SBIR Funding for Development of Novel Electroporation Technologies

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, received a Phase I Small Business Innovation Research grant from the National Institute of Health .



from Content Keyword RSS http://ift.tt/12PC208

via IFTTT